The regulation of cellular bioenergetics is recognised as a key driver of cancer cell proliferation. Identifying key pathways that modulate bioenergetic metabolism is a promising strategy for developing novel therapeutics for cancer treatment.

In this App Note you will learn:

• How the Agilent Seahorse XF Real Time ATP rate assay provides a simple robust workflow that can identify metabolic targets for drug discovery.
• How it can identify metabolic target pathways to be investigated during cancer drug discovery.
• About the dedicated analytic software as a direct way to quantitate and compare the metabolic response of cancer cells to chemicals or genetic modification and differentiate mitochondrial and glycolytic energetic metabolism.

 Brought to you by